Zealand Pharma (ZLDPF)
OTHER OTC:ZLDPF
Holding ZLDPF?
Track your performance easily

Zealand Pharma (ZLDPF) Income Statement

85 Followers

Zealand Pharma Income Statement

Last quarter (Q4 2022), Zealand Pharma's total revenue was kr23.93M, a decrease of -55.71% from the same quarter last year. In Q4, Zealand Pharma's net income was kr-342.45M. See Zealand Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
kr 111.09Mkr 103.99Mkr 292.57Mkr 353.31Mkr 41.33Mkr 37.98M
Cost of Revenue
kr 5.25Mkr 0.00kr 118.81Mkr 90.56Mkr 415.00Kkr 180.24M
Gross Profit
kr 105.83Mkr 103.99Mkr 173.75Mkr 262.75Mkr 40.92Mkr -142.26M
Operating Expense
kr 970.79Mkr 920.59Mkr 1.23Bkr 1.09Bkr 628.86Mkr -794.65M
Operating Income
kr -864.95Mkr -816.60Mkr -1.05Bkr -828.76Mkr -587.94Mkr 652.38M
Net Non Operating Interest Income Expense
kr 96.05Mkr -48.68Mkr 33.65Mkr -6.83Mkr 2.02Mkr -30.79M
Other Income Expense
kr 75.29M-kr 8.22Mkr -4.07Mkr 9.24Mkr 3.46M
Pretax Income
kr -1.08Bkr -972.04Mkr -1.03Bkr -839.65Mkr -576.68Mkr 625.05M
Tax Provision
kr 9.28Mkr -6.43Mkr -8.79Mkr 7.08Mkr -5.14Mkr 43.77M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
kr -1.20Bkr -1.20Bkr -1.02Bkr -846.73Mkr -571.54Mkr 581.28M
Basic EPS
kr -11.90kr -26.02kr -23.75Kkr -22.07kr -16.91kr 18.94
Diluted EPS
kr -11.90kr -26.02kr -23.75Kkr -22.07kr -16.91kr 18.94
Basic Average Shares
kr 94.66Mkr 46.20Mkr 42.87Bkr 38.37Mkr 33.80Mkr 30.69M
Diluted Average Shares
kr 94.66Mkr 46.20Mkr 42.87Mkr 38.37Mkr 33.80Mkr 30.70M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
kr 976.04Mkr 920.59M-kr 1.18Bkr 629.27Mkr -614.41M
Net Income From Continuing And Discontinued Operation
kr -1.20Bkr -1.20Bkr -1.02Bkr -846.73Mkr -571.54Mkr 581.28M
Normalized Income
kr -845.14Mkr -834.12M-kr -843.56Mkr -580.70Mkr 578.06M
Interest Expense
kr 56.46Mkr 56.45M-kr 2.90Mkr 3.21Mkr 15.08M
EBIT
kr -1.02Bkr -915.59M-kr -836.76Mkr -573.47Mkr 640.13M
EBITDA
kr -999.45Mkr -797.63M-kr -836.76Mkr -559.79Mkr 644.64M
Currency in DKK

Zealand Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis